SBI Securities’s Corvus Pharmaceuticals CRVS Stock Holding History
Bought
Maintained
Sold
Other funds holding CRVS
SBI Securities's CRVS Position: Q3 2026 in Review
SBI Securities increased its Corvus Pharmaceuticals (CRVS) stake by 0.02% in Q3 2026, buying an estimated $28 and bringing the position to 11,366 shares worth $131K. The position accounts for ﹤0.01% of the portfolio, ranked #804.
SBI Securities first reported a position in CRVS in Q4 2024 and has held it in 8 quarters since. The position peaked at $170K in Q2 2026. 177 funds tracked by Wall St. Rank hold CRVS as of Q3 2026.
- SBI Securities held 11,366 shares of Corvus Pharmaceuticals worth $131K as of Q3 2026.
- SBI Securities bought 2 Corvus Pharmaceuticals shares in Q3 2026, an estimated $28.
- Corvus Pharmaceuticals made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #804 holding.
- SBI Securities first reported a position in Corvus Pharmaceuticals in Q4 2024 and has held it in 8 quarters since.
- SBI Securities's Corvus Pharmaceuticals position peaked at $170K in Q2 2026.
- 177 funds tracked by Wall St. Rank held Corvus Pharmaceuticals as of Q3 2026.
Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.